Literature DB >> 23608731

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

J Pablo Abonia1, Ting Wen, Emily M Stucke, Tommie Grotjan, Molly S Griffith, Katherine A Kemme, Margaret H Collins, Philip E Putnam, James P Franciosi, Karl F von Tiehl, Brad T Tinkle, Keith A Marsolo, Lisa J Martin, Stephanie M Ware, Marc E Rothenberg.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is an emerging chronic inflammatory disease mediated by immune hypersensitization to multiple foods and strongly associated with atopy and esophageal remodeling.
OBJECTIVE: We provide clinical and molecular evidence indicating a high prevalence of EoE in patients with inherited connective tissue disorders (CTDs).
METHODS: We examined the rate of EoE among patients with CTDs and subsequently analyzed esophageal mRNA transcript profiles in patients with EoE with or without CTD features.
RESULTS: We report a cohort of 42 patients with EoE with a CTD-like syndrome, representing 0.8% of patients with CTDs and 1.3% of patients with EoE within our hospital-wide electronic medical record database and our EoE research registry, respectively. An 8-fold risk of EoE in patients with CTDs (relative risk, 8.1; 95% confidence limit, 5.1-12.9; χ(2)1 = 112.0; P < 10(-3)) was present compared with the general population. Esophageal transcript profiling identified a distinct subset of genes, including COL8A2, in patients with EoE and CTDs.
CONCLUSION: There is a remarkable association of EoE with CTDs and evidence for a differential expression of genes involved in connective tissue repair in this cohort. Thus, we propose stratification of patients with EoE and CTDs into a subset referred to as EoE-CTD.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  BMI; Body mass index; CCHMC; CTD; Cincinnati Children's Hospital Medical Center; Connective tissue disorder; EDS; EGID; EMR; Ehlers-Danlos syndrome; Electronic medical record; EoE; Eosinophilic esophagitis; Eosinophilic gastrointestinal disorder; FBN1; Fibrillin-1 gene; GERD; Gastroesophageal reflux disease; Informatics for Integrating Biology & the Bedside; JHS; Joint hypermobility syndrome; LDS; Loeys-Dietz syndrome; MFS; Marfan syndrome; PPI; Proton pump inhibitor; connective tissue disorders; eosinophil; eosinophilic gastrointestinal disease; hypermobility syndrome; i2b2

Mesh:

Substances:

Year:  2013        PMID: 23608731      PMCID: PMC3807809          DOI: 10.1016/j.jaci.2013.02.030

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  58 in total

1.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.

Authors:  Mark E Lindsay; Dorien Schepers; Nikhita Ajit Bolar; Jefferson J Doyle; Elena Gallo; Justyna Fert-Bober; Marlies J E Kempers; Elliot K Fishman; Yichun Chen; Loretha Myers; Djahita Bjeda; Gretchen Oswald; Abdallah F Elias; Howard P Levy; Britt-Marie Anderlid; Margaret H Yang; Ernie M H F Bongers; Janneke Timmermans; Alan C Braverman; Natalie Canham; Geert R Mortier; Han G Brunner; Peter H Byers; Jennifer Van Eyk; Lut Van Laer; Harry C Dietz; Bart L Loeys
Journal:  Nat Genet       Date:  2012-07-08       Impact factor: 38.330

2.  Quantity and distribution of eosinophils in the gastrointestinal tract of children.

Authors:  Charles W DeBrosse; Justin W Case; Philip E Putnam; Margaret H Collins; Marc E Rothenberg
Journal:  Pediatr Dev Pathol       Date:  2006 May-Jun

Review 3.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

4.  Integration of clinical and genetic data in the i2b2 architecture.

Authors:  Shawn N Murphy; Michael E Mendis; David A Berkowitz; Isaac Kohane; Henry C Chueh
Journal:  AMIA Annu Symp Proc       Date:  2006

5.  Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.

Authors:  Gábor Mátyás; Eliane Arnold; Thierry Carrel; Daniela Baumgartner; Catherine Boileau; Wolfgang Berger; Beat Steinmann
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

6.  TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome.

Authors:  Krishna Kumar Singh; Kathrin Rommel; Anjali Mishra; Matthias Karck; Axel Haverich; Jörg Schmidtke; Mine Arslan-Kirchner
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

7.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

8.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

9.  Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lisa M Wruck; Timothy J Bradley; Steven D Colan; Richard B Devereux; Gloria L Klein; Jennifer S Li; L LuAnn Minich; Stephen M Paridon; Gail D Pearson; Beth F Printz; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; J Philip Saul; Mario P Stylianou; Lynn Mahony
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

10.  IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.

Authors:  Carine Blanchard; Melissa K Mingler; Maria Vicario; J Pablo Abonia; Yi Ying Wu; Thomas X Lu; Margaret H Collins; Philip E Putnam; Susanne I Wells; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2007-12       Impact factor: 10.793

View more
  69 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

Review 2.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

Review 3.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 4.  Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2015-02-07       Impact factor: 22.682

Review 5.  Eosinophilic esophagitis phenotypes: Ready for prime time?

Authors:  Dan Atkins; Glenn T Furuta; Chris A Liacouras; Jonathan M Spergel
Journal:  Pediatr Allergy Immunol       Date:  2017-05-04       Impact factor: 6.377

Review 6.  Eosinophilic Esophagitis.

Authors:  Craig C Reed; Evan S Dellon
Journal:  Med Clin North Am       Date:  2018-11-01       Impact factor: 5.456

Review 7.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

8.  Epidemiology of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2014-03-19       Impact factor: 3.806

9.  Genetic and epigenetic underpinnings of eosinophilic esophagitis.

Authors:  Joseph D Sherrill; Marc E Rothenberg
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

10.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.